SALES AND PURCHASE AGREEMENT BETWEEN BITMAINTECH PTE. LTD. (“Bitmain”) AND Riot Blockchain, Inc (“Purchaser”)Sales and Purchase Agreement • August 27th, 2020 • Riot Blockchain, Inc. • In vitro & in vivo diagnostic substances
This agreement (this “Agreement”) is made on 24 August 2020 by and between Bitmaintech Pte. Ltd. (“Bitmain”) (UEN: 201610324R), with its principal place of business at 8 Kallang Avenue, Aperia Tower 1, #09-03/04, Singapore, 339509, and Riot Blockchain, Inc (the “Purchaser”) with its principal place of business at 202 6th Street, Suite 401, Castle Rock, CO 80104, USA.
ContractSales and Purchase Agreement • August 27th, 2020 • Riot Blockchain, Inc. • In vitro & in vivo diagnostic substances
[****] Certain information in this exhibit has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) would likely cause competitive harm to the registrant if publicly disclosed.
